A recent Mendelian randomization analysis concluded that genetically predicted glucose and insulin-related traits were positively associated with breast cancer risk, results suggesting their role in the obesity-related etiology of breast cancer (37). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.